Zimmer Biomet HoldingsMEX:ZBH 59 EV-to-FCF is 16.79 as of Jul. 03, 2026, which is 30% below its 10-year median of 24.09. GuruFocus rates MEX:ZBH with a GF Score™ of 59/100 and a GF Value™ of MXN2,166.88 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks better than 63.16% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Zimmer Biomet Holdings's Enterprise Value is MXN420,058 Mil.
Zimmer Biomet Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN25,014 Mil. Therefore, Zimmer Biomet Holdings's EV-to-FCF for today is 16.79.
The historical rank and industry rank for Zimmer Biomet Holdings's EV-to-FCF or its related term are showing as below:
MEX:ZBH'
s EV-to-FCF Range Over the Past 10 Years
Min: 16.93 Med: 24.09 Max: 48.02
Current: 17.52
During the past 13 years, the highest EV-to-FCF of Zimmer Biomet Holdings was 48.02. The lowest was 16.93. And the median was 24.09.
MEX:ZBH's EV-to-FCF is ranked better than 63.16% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.12
vs MEX:ZBH: 17.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zimmer Biomet Holdings's PE Ratio (TTM) for today is calculated as:
Zimmer Biomet Holdings's share price for today is MXN1502.00.
Zimmer Biomet Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN70.591.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Zimmer Biomet Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's EV-to-FCF falls into.
Zimmer Biomet Holdings's current Enterprise Value is MXN420,058 Mil.
Zimmer Biomet Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN25,014 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (MEX:ZBH) has a EV-to-FCF of 16.79 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zimmer Biomet Holdings and its competitors. This is 30% below median its historical median of 24.09. Over the past decade, Zimmer Biomet Holdings' EV-to-FCF has ranged from 16.93 to 48.02. According to the industry distribution chart, Zimmer Biomet Holdings ranks #154 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 36.8%.
Is Zimmer Biomet Holdings' EV-to-FCF too high?
Zimmer Biomet Holdings' current EV-to-FCF of 16.79 is 30% below median its 10-year median of 24.09. Over the past 10 years, this metric has ranged from a low of 16.93 to a high of 48.02. The Medical Devices & Instruments industry median EV-to-FCF is 23.12. Zimmer Biomet Holdings' value of 16.79 is 27.4% below this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #154 out of 418 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zimmer Biomet Holdings has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' EV-to-FCF compare to STE and PEN?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #154 out of 418 companies for EV-to-FCF. This puts Zimmer Biomet Holdings in the upper half of its industry. The industry median EV-to-FCF is 23.12. Zimmer Biomet Holdings' value of 16.79 is 27.4% below this benchmark. Historically, Zimmer Biomet Holdings' own EV-to-FCF has ranged from 16.93 to 48.02 over the past decade. While the company's 10-year median is 24.09 vs. the industry median of 23.12, Zimmer Biomet Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current EV-to-FCF of 16.79 is 27.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current EV-to-FCF is 16.79, which is 30% below median its own 10-year median of 24.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (MEX:ZBH) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN2,166.88, compared to a current price of MXN1,502.00 — trading 30.7% below its estimated fair value. The current EV-to-FCF is 16.79, which is 30% below median its 10-year median of 24.09 and 27.4% below the Medical Devices & Instruments industry median of 23.12. Zimmer Biomet Holdings' overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Zimmer Biomet Holdings (MEX:ZBH), the current EV-to-FCF is 16.79 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (MEX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of MXN1,502.00 is trading 30.7% below its estimated GF Value™ of MXN2,166.88.
GuruFocus considers Zimmer Biomet Holdings to be Significantly Undervalued.
Key valuation signals for MEX:ZBH:
EV-to-FCF: 16.79 (30% below median its 10-year median of 24.09)
GF Value™: MXN2,166.88 vs. price of MXN1,502.00 (30.7% below fair value)
Industry Position: 27.4% below the Medical Devices & Instruments median (#154 of 418)
No single metric tells the full story. See the MEX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
59GF Score
Get the complete analysis for MEX:ZBH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ZBH has been successfully added to your 
